Page last updated: 2024-08-24

tirofiban and Diabetic Angiopathies

tirofiban has been researched along with Diabetic Angiopathies in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aroney, CN; Gunasekara, AP; Walters, DL	1
Angiolillo, D; Arora, U; Atar, D; Malinin, A; Pokov, A; Serebruany, V	1
Aguiar, C; Almeida, M; de Araujo Goncalves, P; Ferreira, J; Pereira Machado, F; Raposo, L; Seabra-Gomes, R; Teles, R	1
Bertrand, M; Demopoulos, LA; DiBattiste, PM; Grines, CL; Harris, KE; Herrmann, HC; Meier, B; Moliterno, DJ; Powers, ER; Roffi, M; Topol, EJ	1

Trials

1 trial(s) available for tirofiban and Diabetic Angiopathies

Article	Year
Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up. Circulation, 2002, Jun-11, Volume: 105, Issue:23 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Coronary Circulation; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Insulin; Integrins; Kinetics; Male; Middle Aged; Neovascularization, Pathologic; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine	2002

Article

Year

Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up.

Circulation, 2002, Jun-11, Volume: 105, Issue:23

Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Coronary Circulation; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Insulin; Integrins; Kinetics; Male; Middle Aged; Neovascularization, Pathologic; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine

2002

Other Studies

3 other study(ies) available for tirofiban and Diabetic Angiopathies

Article	Year
Comparison of abciximab with "high-dose" tirofiban in patients undergoing percutaneous coronary intervention. International journal of cardiology, 2006, Apr-28, Volume: 109, Issue:1 Topics: Abciximab; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Australia; Diabetic Angiopathies; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Syndrome; Tirofiban; Troponin; Tyrosine	2006
Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial? Thrombosis research, 2007, Volume: 119, Issue:2 Topics: Aged; Blood Platelets; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Cell Surface; Tirofiban; Tyrosine	2007
Complementary effects of sirolimus-eluting stents and glycoprotein IIb/IIIa inhibitors for percutaneous coronary intervention in diabetic patients: one-year follow up of a single-centre registry. Heart (British Cardiac Society), 2006, Volume: 92, Issue:8 Topics: Coronary Restenosis; Diabetic Angiopathies; Disease-Free Survival; Drug Combinations; Drug Implants; Eptifibatide; Follow-Up Studies; Humans; Immunosuppressive Agents; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sirolimus; Stents; Tirofiban; Tyrosine	2006